NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

On market cap it is as if Larry Smith is negotiating for large pharma. It's been that way for a while. He's a fan of BMY.

Nonetheless, he concedes the valuation could go much higher.

....this could result in perhaps a $5 billion market valuation at some point. Please note that I am basing this on the perception. If indeed, DCVax-L is approved for newly diagnosed GBM, I think the valuation could be meaningfully higher.

Of course it could. DCVax-L is meant to treat all operable solid tumors. That is speculative vale. If it is approved for nGBM, the value perception for other future indications will rise dramatically. IMHO.